Hui Jun Lim
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Viral-associated cancers and disorders
Papers in
- Co-authors
- Jialin Yang (2 shared papers)Philip Crowe (2 shared papers)Chin‐Ann Johnny Ong (10 shared papers)William J. Ledger (1 shared paper)Joey Wee‐Shan Tan (9 shared papers)Melissa Ching Ching Teo (4 shared papers)Sebastian Dango (2 shared papers)Hanno Steen (2 shared papers)
- Journals
- Scientific Reports (2 papers)Critical Reviews in Oncology/Hematology (2 papers)The Journal of Cell Biology (1 paper)Anticancer Research (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- SingaporeAustraliaUnited Kingdom
In The Last Decade
Hui Jun Lim
25 papers receiving 493 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 97
- Oncology 149
- Molecular Biology 273
- Pathology and Forensic Medicine 54
- Reproductive Medicine 25
Countries citing papers authored by Hui Jun Lim
This map shows the geographic impact of Hui Jun Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Jun Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Jun Lim more than expected).
Fields of papers citing papers by Hui Jun Lim
This network shows the impact of papers produced by Hui Jun Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Jun Lim. The network helps show where Hui Jun Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Jun Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 137 | |
| 2 | 2013 | 104 | |
| 3 | 2007 | 47 | |
| 4 | 2019 | 42 | |
| 5 | 2016 | 32 | |
| 6 | 2016 | 23 | |
| 7 | 2015 | 18 | |
| 8 | 2023 | 12 | |
| 9 | 2019 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 6 | |
| 14 | 2015 | 6 | |
| 15 | 2019 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2013 | 3 |
About Hui Jun Lim
Hui Jun Lim is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 26 papers that have together received 497 indexed citations. Recurring topics across this work include Vascular Tumors and Angiosarcomas (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Cardiac tumors and thrombi (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (97 citations), Oncology (149 citations), Molecular Biology (273 citations), Pathology and Forensic Medicine (54 citations) and Reproductive Medicine (25 citations). Hui Jun Lim has collaborated with scholars based in Singapore, Australia and United Kingdom. Frequent co-authors include Jialin Yang, Philip Crowe, Chin‐Ann Johnny Ong, William J. Ledger, Joey Wee‐Shan Tan, Melissa Ching Ching Teo, Sebastian Dango, Hanno Steen, J. Wade Harper and Yuying Luo. Their work appears in journals such as Scientific Reports, Critical Reviews in Oncology/Hematology, The Journal of Cell Biology, Anticancer Research and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.